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ABSTRACT

Introduction We prospectively investigated the
associations between diabetes-related family conflict,
parent engagement in child type 1 diabetes (T1D) care,
and child glycated hemoglobin (HbA1c) in 127 families of
school-age children who we recruited within the first year
of their T1D diagnosis.
Research design and methods Parents completed the
Diabetes Family Conflict Scale-Revised (DFCS-R) to assess
for diabetes-related family conflict and the Diabetes Self-
Management Questionnaire-Brief (DSMQ-Brief) to assess
parent engagement in child T1D care at the initial study
visit (T1) and at 12 (T2) and 27 (T3) months later. We also
collected child HbA1c at these time points. Our analyses
included Pearson correlations and repeated measures
linear mixed models controlling for child age, sex, and T1D
duration at T1.
Results Parents’ DFCS-R scores negatively correlated
with DSMQ-Brief scores (r=−0.13, p<0.05) and positively
correlated with children’s HbA1c (r=0.26, p<0.001). In our
linear mixed models, parents’ DSMQ-Brief scores were
unchanged at T2 (β=−0.71, 95% CI −1.59 to 0.16) and
higher at T3 (β=8.01, 95% CI 6.89 to 9.13) compared
with T1, and there was an association between increasing
DFCS-R and decreasing DSMQ-Brief scores (β=−0.14,
95% CI −0.21 to −0.06). Child HbA1c values were
significantly higher at T2 (β=0.66, 95% CI 0.38 to 0.94)
and T3 (β=0.95, 95% CI 0.63 to 1.27) compared with T1,
and there was an association between increasing DFCS-R
scores and increasing child HbA1c (β=0.04, 95% CI 0.02
to 0.06).
Conclusions Increasing diabetes-specific family conflict
early in T1D may associate with decreasing parent
engagement in child T1D care and increasing child HbA1c,
suggesting a need to assess and intervene on diabetes-
specific family conflict.
Trial registration number NCT03698708.

INTRODUCTION
Youth with type 1 diabetes (T1D) experience
dramatic reductions in glycated hemoglobin
(HbA1c) levels after initiation of insulin
therapy,1 but glycemic levels tend to increase
in many youth over the next 12–24 months.2
Prior studies have addressed associations

Significance of this study
What is already known about this subject?
►► Prior studies have demonstrated associations be-

tween diabetes-specific family conflict and suboptimal glycemic levels and self-care engagement in
families of adolescents and families of youth who
are not in the recent-onset period of type 1 diabetes
(T1D).

What are the new findings?
►► In this 27-
month prospective longitudinal study,

parents of young school-age children with recent-
onset T1D reported clinically noteworthy levels of
diabetes-specific family conflict that increased with
time and associated with decreasing parent engagement in child T1D care and increasing child glycemic
levels over time.
►► Because diabetes-specific family conflict is potentially treatable, our findings highlight a new target for
future clinical intervention for these families.

How might these results change the focus of
research or clinical practice?
►► Diabetes care teams should consider screening for

diabetes-specific conflict among families of young
school-
age children with recent-
onset T1D as it
appears to associate with suboptimal changes in
parent engagement in child T1D care and child glycemic levels.

between increasing glycemic levels and both
loss of residual beta cell function (also known
as the ‘honeymoon period’) and the onset of
puberty in youth.3 4 Yet few studies have examined the relationship between parent/child
factors and longitudinal child glycemic levels
in the first 24 months after families establish
diabetes care, a period that might reflect the
experiences and outcomes of children with
recent-onset T1D.
The recent-onset period of T1D is a unique
time for parents and children.5 First, this
period requires rapid knowledge and skill
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acquisition for T1D management in parents and children, including glucose monitoring, insulin administration, and carbohydrate counting. Second, it is a period of
T1D when children are often vulnerable to wide fluctuations in their blood glucose levels because of residual beta
cell function.1 According to international guidelines,6
it is recommended for parents of children with recent-
onset T1D to oversee and even complete much of the
daily T1D management on behalf of their child, which
could underscore the importance of examining parent/
child factors as they relate to children’s glycemia. For
families of youth with T1D who are beyond 24 months
postdiagnosis, studies suggest that diabetes-
specific
family conflict may be an important parent/child factor
to include when examining child glycemic levels.7–13
Diabetes-specific family conflict is a construct that reflects
how much a parent and child with T1D argue about T1D
management.14 Related, it may be important to include
a measure of either youth or parent engagement with
T1D care to assess how often parents or youth are participating in T1D management.12 15 There are many cross-
sectional studies conducted in adolescents with T1D
that report associations between higher diabetes-specific
family conflict and suboptimal youth engagement in T1D
care and HbA1c.9–12 15 There is also a study conducted in
families of adolescents with T1D which found a longitudinal association between diabetes-specific family conflict
and youth HbA1c that was partially mediated by youth
engagement in T1D care.16
As a possible explanation for why diabetes-
specific
family conflict could relate to T1D engagement and
youth HbA1c, it may be that parent–child conflict around
diabetes self-care tasks and shared responsibility of those
tasks impedes parents’ beneficial involvement and collaboration with their youth’s T1D care, leading to suboptimal HbA1c levels.8 15 In this way, diabetes-specific family
conflict, which is increasingly recognized as a potentially
modifiable factor in diabetes management, could also be
an important clinical target for intervention.7 8 10 15 For
families of younger children with T1D and families of
children with recent-onset T1D, we know far less about
how diabetes-specific family conflict may relate to suboptimal T1D engagement or child HbA1c and this could
represent a critical gap in knowledge related to the clinical management of these families.
Therefore, this study expands on previous literature
by investigating the association between family conflict,
parent engagement in child T1D care, and HbA1c in
a sample of children recently diagnosed with T1D.
Compared with prior studies, the patient cohort examined here is younger (mean age of 7 years), closer to
their T1D diagnosis (within 12 months), and the study
design includes a longer follow-
up period (up to 27
months) to assure data collection beyond the recent-
onset period. We specifically selected a measure of parent
engagement in child T1D care versus child engagement
because we anticipated parents would play a significant
role in their child’s T1D care. Precisely, we hypothesized
2

that parents would report diabetes-specific family conflict
despite their child’s young age and minimal time since
T1D onset and that increasing family conflict over time
would associate with decreasing parent engagement in
child T1D care and increasing child HbA1c levels.
METHODS
Participants and procedures
We recruited parents and children aged 5–9 years old and
within 12 months of their T1D diagnosis at two pediatric
diabetes clinics in the USA to participate in a prospective longitudinal study examining psychosocial factors
that may contribute to youth glycemic levels during the
recent-onset period of T1D (TACKLE: Treatment Adherence and Control in Kids: Longitudinal Evaluation).
Eligible families had a child within 12 months of his or
her T1D diagnosis, who was between 5 and 9 years old,
used intensive insulin therapy (insulin pump or multiple
daily injections), and spoke English. Families excluded
from participation were families of children diagnosed
with a developmental delay, severe psychiatric disorder,
or comorbid chronic condition, families of children with
type 2 or monogenic diabetes, and children taking medications that may impact glycemic levels.
Parents provided informed consent and permission for
their child to participate. Children ≥7 years old provided
assent; this included any child who turned 7 years old
while participating in the longitudinal study. For each
parent and child dyad, we collected child HbA1c levels
and parent survey responses at the initial study visit (T1)
and at 12 and 27 months later (T2 and T3, respectively).
We targeted parents who self-identified as assuming a
primary role in the daily management of their child’s
T1D and had the same parent complete surveys at each
time point. While the recent-onset period may conclude
at 24 months, we include data at 27 months to assure that
we are crossing the threshold beyond the recent-onset
period with one data collection point in the ‘established
diabetes’ period. We compensated parents for participation at each study visit using a clin card or gift card. Children received a toy valued at US$10 for completing an
HbA1c kit at each time point.
Measures
Demographics
Parents reported all demographic information at the
initial study visit (T1). This included child age, child sex,
race/ethnicity, duration of T1D, caregiver relation to
child, caregiver age, caregiver marital status, and family
income.
Hemoglobin A1c
We collected children’s HbA1c by a finger-stick blood
sample and capillary tube collection at all study visits (T1–
T3). We analyzed all study samples at a central laboratory
using automated high-
performance liquid chromatography (reference range 4.0%–6.0% (20–42 mmol/mol);
Tosoh Corporation, San Francisco, California).17 In the
BMJ Open Diab Res Care 2021;9:e002461. doi:10.1136/bmjdrc-2021-002461
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rare event of a missing or diluted laboratory sample, we
used children’s most current point-of-care HbA1c values.
Results suggested >0.90 reliability between children’s
available point-of-care and laboratory-based HbA1c.
Diabetes Family Conflict
Parents used the Diabetes Family Conflict Scale-Revised
(DFCS-R)14 to report on their perceptions of diabetes-
specific family conflict. Parents completed this survey at
all study visits (T1–T3). Items of the DFCS-R identify 19
T1D management tasks, such as remembering to give shots
or bolus for insulin and recognizing symptoms of a low blood
glucose and telling other people about diabetes. According
to the standardized instructions, parents responded to
items using a Likert scale based on how often they argue
with their child with T1D about each behavior (from
1=never argue to 3=always argue).14 We scored parents’
DFCS-R surveys based on total scores (range: 19–57),
with higher scores reflecting greater levels of conflict.
The DFCS-R is valid for use in parents of children with
T1D and appropriate for administration in a research or
clinical setting.14
Diabetes Self-Management
The Diabetes Self-
Management Questionnaire-
Brief
(DSMQ-Brief)18 is a nine-item measure of engagement in
T1D care over the past month. It includes items specific
to insulin use (How often have you administered insulin
more than 30 minutes late or forgotten to administer it at all?),
glucose monitoring (How often did you check blood glucose
within 30 minutes before a meal?), diet (Do you usually count
carbs, measure, or weigh food, or use exchanges to figure out how
much to give?), and exercise (When your child got a different
amount of exercise than usual, how often did you make changes
in the meal plan or insulin amount?).18 Parents responded
to each item to characterize their level of engagement in
their child’s T1D care, with higher scores corresponding
to higher levels of parent engagement. The DSMQ-Brief
scores can range from 6 to 35. Parents completed this
survey at all study visits (T1–T3). The DSMQ-Brief is valid
for use in parents of children with T1D and in research
and clinical settings.18
Statistical analysis
We performed descriptive and analytic statistical analyses
using the Stata/SE V.15.1. We adopted an alpha of p<0.05
to denote statistical significance and report 95% CI.
Our descriptive statistics included frequencies,
percentages, means, and SD of our demographic and
outcome data. We calculated Pearson correlations for
the DSMQ-Brief, DFCS-R, and child HbA1c. To test our
primary hypothesis, we used repeated measures linear
mixed models (LMMs) to evaluate associations over
time (T1–T3) between parents’ DSMQ-Brief scores and
child HbA1c with parents’ DFCS-R total scores. For these
models, we controlled for child initial study visit age,
child sex, and duration of T1D, and we used participant
as the fixed effect.
BMJ Open Diab Res Care 2021;9:e002461. doi:10.1136/bmjdrc-2021-002461

RESULTS
Sample characteristics
The analyzed sample included 127 parent–child dyads.
At the initial study visit (T1), children had a mean time
since diagnosis of 4.7±3.3 months and a mean age of
7.8±1.3 years. There were 65 (51%) girls and 62 (49%)
boys in the sample. Parents in the study were predominantly mothers (87%) and had a mean age of 36.6±6.4
years at T1. The parent–child dyads self-reported their
race and ethnicity. The sample was 84% white, 10% black/
African American, and 6% preferring not to report race.
Of the parents, 11% also indicated that they identified
as Hispanic/Latinx. Parents self-reported family income.
Approximately 50% of the sample reported a household
income at or below the 2019 US median income of $68
703.19
Measures and outcomes descriptives
At the initial study visit (T1), parents’ mean DFCS-
R
total score was 23.18±6.15, parents’ DMSQ-Brief score
was 27.77±3.88, and child HbA1c was 7.61%±1.37%. At
12 months (T2), parents’ mean DFCS-R total score was
24.78±6.68, parents’ DMSQ-Brief score was 26.78±4.40,
and child HbA1c was 8.26%±1.23%. At 27 months
(T3), parents’ mean DFCS-R total score was 25.35±6.42,
Brief score was 35.49±5.31, and child
parents’ DMSQ-
HbA1c was 8.57%±1.40%.
Bivariate correlations
Across time points, parents’ DFCS-R total scores negatively correlated with their DSMQ-Brief scores (r=−0.13,
p<0.05) and positively correlated with children’s HbA1c
levels (r=0.26, p<0.001). Figures 1 and 2 show parents’
DSMQ-Brief scores and child HbA1c values, respectively,
and DFCS-R total scores at T1–T3.
Linear mixed models
In a series of LMMs, we explored the associations of
parents’ DFCS-R total scores with parent-reported DSMQ-
Brief scores and children’s HbA1c levels, while controlling
for time, child age and duration of T1D at T1, and child
sex. In the first model, there was a time effect for families’
DSMQ-Brief scores. Compared with T1, parent-reported
DSMQ-Brief scores were unchanged at T2 (β=−0.71, 95%
CI −1.59 to 0.16) and significantly higher at T3 (β=8.01,
95% CI 6.89 to 9.13). However, consistent with the study
hypothesis, we observed a significant effect of parent-
reported DFCS-R total scores, such that for each unit
increase in conflict there was 0.14 decrease in parent-
reported DSMQ-
Brief scores (β=−0.14, 95% CI −0.21
to −0.06). In the second model, there was a significant
time effect for children’s HbA1c levels. Compared with
T1, child HbA1c values were significantly higher at T2
(β=0.66, 95% CI 0.38 to 0.94) and T3 (β=0.95, 95% CI
0.63 to 1.27). Also consistent with the study hypothesis,
we observed a statistically significant association between
R total scores and increasing child
increasing DFCS-
HbA1c levels, such that for each unit increase in conflict
3
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Figure 1 Parents’ DSMQ-Brief scores and DFCS-R total scores at initial study visit (T1), at 12 months (T2), and at 27 months
(T3). DFCS-R, Diabetes Family Conflict Scale-Revised; DSMQ-Brief, Diabetes Self-Management Questionnaire-Brief.

there was 0.04% increase in child HbA1c (β=0.04, 95%
CI 0.02 to 0.06).
DISCUSSION
In a sample of families of young school-age children with
recent-onset T1D, we found that parents reported the
presence of diabetes-specific family conflict and that their
perceptions of conflict increased over the study period.
age chilSpecifically, at T1, parents of young school-
dren with recent-onset T1D reported levels of diabetes-
specific family conflict that were comparable with levels
reported by parents of adolescents with T1D.11 12 14 16 This
is clinically important because any level of family conflict
can undermine parent–child collaboration to perform
diabetes care tasks as well as impact their perceptions of
quality of life.11 12 14 Related, the nearly two-point increase
in parents’ mean diabetes-specific family conflict scores
between T1 and T3 is also clinically important as it highlights the possibility that families who report greater
diabetes-specific family conflict close to diabetes onset
will report increasing conflict over time as families transition from recent-onset to established T1D care periods.
Focusing on our primary hypothesis, in a series of
repeated measures LMMs that controlled for time, child
4

age, time since diagnosis, and child sex, our results
suggested longitudinal associations between parent-
reported diabetes-
specific family conflict such that
increasing conflict related to decreasing parent engagement in child T1D care. We also saw a longitudinal
association between increasing diabetes-
specific family
conflict and increasing child HbA1c. Thus, the results of
our LMMs highlight how diabetes-specific family conflict
could negatively affect families. If parents and children
are arguing more during the recent-onset period, it is
possible this conflict could make it harder for them to
establish effective parent–child collaboration for diabetes
care, thereby leading to decreasing perceptions of parent
engagement in T1D care and increasing child HbA1c. As
noted earlier, other studies have found similar associations between family conflict, youth engagement in T1D
care, and HbA1c in adolescents,8–12 15 16 but to our knowledge this is the first time research has provided evidence
showing these longitudinal associations in children
younger than adolescents and the first time documenting
these associations up to 2.5 years beyond diabetes onset
for children.
We also found significant time effects for parent
engagement in child T1D care and child HbA1c. Notably,
BMJ Open Diab Res Care 2021;9:e002461. doi:10.1136/bmjdrc-2021-002461
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Figure 2 Children’s HbA1c and parents’ DFCS-R total scores at initial study visit (T1), at 12 months (T2), and at 27 months
(T3). DFCS-R, Diabetes Family Conflict Scale-Revised; HbA1c, glycated hemoglobin.

the time effect for parent engagement in child T1D care
suggested that parents reported increasing DSMQ-Brief
scores between T1 and T3. This result may provide additional evidence to support the notion that families will
do better with diabetes self-care when they have adequate
knowledge and resources to start off with more optimal
levels of parent engagement in child T1D care. The
time effect for child HbA1c suggested that children with
higher HbA1c levels at T1 also had increasing HbA1c
levels at T2 and T3, suggesting that even early in T1D
some children may experience a trajectory of increasing
HbA1c levels that might translate into greater vulnerability for acute (such as diabetes ketoacidosis) and long-
term sequela of suboptimal glucose levels (including
nephropathy, neuropathy, and retinopathy).20
Also, with regard to the temporal effects for child
HbA1c, it may be important to consider the potential role of the honeymoon period.1 While previous
studies have presupposed the end of the honeymoon
period to be one explanation for why children may
experience an increase in their HbA1c during the
recent-onset period,1–3 increasing diabetes-
specific
family conflict could offer an alternative hypothesis
and a modifiable target. It is possible that parents and
BMJ Open Diab Res Care 2021;9:e002461. doi:10.1136/bmjdrc-2021-002461

children could perceive greater stress and conflict
if the loss of residual endogenous insulin secretion
results in greater effort to appropriately care for T1D
(ie, the end of the honeymoon period contributes to
increasing conflict). Similarly, it is possible the presence of conflict could hamper effective communication about diabetes care, leading to a decrease in
parent engagement in child T1D care and rising child
HbA1c levels (ie, increasing conflict reduces parent
engagement in child T1D care, contributing to rising
HbA1c). Considering these results, one clinical implication may be to initiate screening for diabetes-specific
family conflict during the recent-onset period. The
DFCS-R14 is a short survey, validated for use in parents
and youth, which may be scalable for in clinic use.
Moreover, for families who screen positive for conflict,
there are successful interventions that reduce family
conflict by improving family communication, collaboration, and empathy.21–24 Thus, it is possible early
detection and treatment for diabetes-specific conflict
could help families of young school-age children to
establish a beneficial collaboration for daily parent
engagement in child T1D care and to achieve optimal
HbA1c levels closer to diagnosis.
5
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Although the insights contributed by this study are
clinically meaningful, we recognize study limitations.
These include the lack of racial and ethnic diversity
of the sample, the potential over-reliance on mothers’
perspectives, the use of a parent-report measure of
parent engagement in child T1D care versus objective assessment via frequency of self-
monitoring
blood glucose or insulin Bolus scores,25 and potential
confounding due to differences in when each child
exited the honeymoon period. In the future, it will be
important to examine these associations in a cohort
of families of school-age children with recent-onset
T1D from diverse racial and ethnic backgrounds
to increase generalizability of the results. Indeed,
increasing evidence draws attention to the impact of
long-standing health, social, and economic inequities
in the USA on child glycemic levels, making it essential
to pursue additional studies to better understand how
diabetes-specific family conflict is associated with child
HbA1c.26 Our study procedures enabled us to recruit
any parent who self-identified as providing primary
care for their child’s T1D management, although we
primarily had mothers participating. In the future,
studies should attempt to solicit perceptions from
fathers or other caregivers.7 27 Another focus of future
research should be to confirm our study findings
using objective measures of parent engagement in
child T1D care, such as the days of continuous glucose
monitor use and children’s insulin Bolus score.25 Similarly, future studies should include the methodology to
assess for biomarkers (eg, C peptide) that may signal
residual beta cell function to personalize how long
young school-age children with T1D are experiencing
the honeymoon effect and how exiting this period
specifically relates to parents’ perceptions of diabetes-
specific family conflict, parent engagement in child
T1D care, and children’s HbA1c levels.6 28 Strengths of
this study include its prospective, longitudinal design,
with repeated assessments up to 27 months poststudy
enrollment, its relatively large cohort of children with
recent-onset T1D, its use of a central laboratory to
analyze the study-specific HbA1c samples, and its use
of validated parent-report surveys.
In conclusion, this study highlights the importance
of assessing diabetes-
specific family conflict, especially in the context of optimizing glycemic levels and
encouraging optimal parent engagement in child T1D
care among families of young school-age children with
recent-onset T1D. We believe that it is sustainable to
screen for diabetes-specific family conflict using validated surveys. Moreover, because conflict is potentially
modifiable,21–24 it may be a promising novel target
for interventions that aim to improve glycemic levels
for children experiencing increasing HbA1c in the
recent-onset period. Future studies should be aimed
at assessing implementation of screening for diabetes-
specific family conflict in the recent-
onset period
and the efficacy of interventions to help parents and
6

children establish a beneficial collaboration for T1D
care tasks and a trajectory of optimal child HbA1c.
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